Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system
- PMID: 16439141
- DOI: 10.1016/j.nbd.2005.12.003
Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system
Abstract
Sporadic Parkinson's disease (PD) is most likely caused by a combination of environmental exposures and genetic susceptibilities, although there are rare monogenic forms of the disease. Mitochondrial impairment at complex I, oxidative stress, alpha-synuclein aggregation, and dysfunctional protein degradation, have been implicated in PD pathogenesis, but how they are related to each other is unclear. To further evaluated PD pathogenesis here, we used in vivo and in vitro models of chronic low-grade complex I inhibition with the pesticide rotenone. Chronic rotenone exposure in vivo caused oxidative modification of DJ-1, accumulation of alpha-synuclein, and proteasomal impairment. Interestingly, the effects become more regionally restricted such that systemic complex I inhibition eventually results in highly selective degeneration of the nigrostriatal pathway. DJ-1 modifications, alpha-synuclein accumulation, and proteasomal dysfunction were also seen in vitro and these effects could be prevented with alpha-tocopherol. Thus, chronic exposure to a pesticide and mitochondrial toxin brings into play three systems, DJ-1, alpha-synuclein, and the ubiquitin-proteasome system, and implies that mitochondrial dysfunction and oxidative stress link environmental and genetic forms of the disease.
Similar articles
-
Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.Neurochem Int. 2009 Dec;55(8):760-7. doi: 10.1016/j.neuint.2009.07.009. Epub 2009 Aug 6. Neurochem Int. 2009. PMID: 19647776
-
α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatment.J Mol Neurosci. 2010 Oct;42(2):243-54. doi: 10.1007/s12031-010-9378-1. Epub 2010 May 13. J Mol Neurosci. 2010. PMID: 20464527
-
Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.Exp Neurol. 2003 Jan;179(1):9-16. doi: 10.1006/exnr.2002.8072. Exp Neurol. 2003. PMID: 12504863
-
Recessive Parkinson's disease.Mov Disord. 2006 Jul;21(7):885-93. doi: 10.1002/mds.20841. Mov Disord. 2006. PMID: 16615060 Review.
-
Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.Exp Neurol. 2009 Aug;218(2):235-46. doi: 10.1016/j.expneurol.2009.03.006. Epub 2009 Mar 18. Exp Neurol. 2009. PMID: 19303005 Review.
Cited by
-
Neurodegeneration in the centrally-projecting Edinger-Westphal nucleus contributes to the non-motor symptoms of Parkinson's disease in the rat.J Neuroinflammation. 2022 Feb 2;19(1):31. doi: 10.1186/s12974-022-02399-w. J Neuroinflammation. 2022. PMID: 35109869 Free PMC article.
-
Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone.J Neurosci. 2007 Jul 4;27(27):7310-7. doi: 10.1523/JNEUROSCI.0212-07.2007. J Neurosci. 2007. PMID: 17611283 Free PMC article.
-
New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases.Pharmaceuticals (Basel). 2018 Oct 19;11(4):109. doi: 10.3390/ph11040109. Pharmaceuticals (Basel). 2018. PMID: 30347635 Free PMC article. Review.
-
Neurotoxins and neurotoxicity mechanisms. An overview.Neurotox Res. 2006 Dec;10(3-4):263-87. doi: 10.1007/BF03033362. Neurotox Res. 2006. PMID: 17197375 Review.
-
Rotenone aggravates PD-like pathology in A53T mutant human α-synuclein transgenic mice in an age-dependent manner.Front Aging Neurosci. 2022 Aug 8;14:842380. doi: 10.3389/fnagi.2022.842380. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36004003 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical